V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009161 | 280006393 | 1.85 | 67 | Palliative (P) | 2015-08-04 | 2015-08-12 | TRASTUZUMAB | N | N | 280030164 | NIVOLUMAB |
| 280009162 | 280006396 | 1.73 | 84.5 | null | null | 2015-06-19 | Cisplatin + Doxorubicin | null | null | 280030165 | METHOTREXATE HIGH DOSE |
| 280009163 | 280010757 | 1.72 | 56.7 | Not known (9) | 2018-02-08 | 2018-02-11 | LANREOTIDE | 02 | N | 280030165 | NIVOLUMAB |
| 280009164 | 280006398 | 1.65 | 65.3 | Palliative (P) | null | 2016-12-27 | Capecitabine + Oxaliplatin 21day | N | N | 280030167 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009165 | 280009345 | 1.78 | null | Not known (9) | 2013-06-16 | 2013-06-19 | INTERFERON | 02 | N | 280030167 | BUSULFAN + MELPHALAN |
| 280009166 | 280006400 | 1.8 | 85.8 | Adjuvant (A) | 2017-05-17 | 2017-05-28 | STS Rhabdo rel BERNIE Vinor Cyclo | N | N | 280030172 | CARBOPLATIN + CETUXIMAB + FU |
| 280009167 | 280009346 | 1.86 | 88.7 | Palliative (P) | 2018-12-12 | 2018-12-22 | Carbo F | null | null | 280030174 | CARBO + FLUOROURACIL |
| 280009168 | 280006401 | 1.8 | 67.4 | null | 2015-05-22 | 2015-08-19 | CISPLATIN + FLUOROURACIL + RT | N | N | 280030176 | RITUXIMAB |
| 280009169 | 280006402 | 1.8 | 0 | Palliative (P) | 2015-09-07 | 2015-09-07 | Carboplatin + Cetux + FU (>Cycle 2) | N | null | 280030180 | BCG |
| 280009170 | 280006404 | 1.74 | 82.7 | Palliative (P) | 2015-12-14 | 2015-12-21 | CISPLATIN + ETOPOSIDE | 02 | N | 280030184 | CISPLATIN + DOXORUBICIN |
| 280009171 | 280006405 | 1.77 | 53 | Palliative (P) | 2015-03-23 | 2015-03-24 | STS Rhabdo rel BERNIE Vinor Cyclo | 02 | N | 280030187 | IMATINIB |
| 280009172 | 280006407 | 1.87 | 83.95 | Neo-adjuvant (N) | 2017-02-02 | 2017-02-24 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 280030188 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280009173 | 280006407 | 1.72 | null | Palliative (P) | null | 2015-03-27 | EOX | 02 | N | 280030188 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009174 | 280006409 | 1.86 | 90 | Palliative (P) | 2016-04-19 | 2016-04-19 | DACTINOMYCIN + CYCLO + VINCRISTINE | N | N | 280030190 | ICE |
| 280009175 | 280006414 | 1.71 | 94 | Palliative (P) | 2017-04-14 | 2017-04-15 | Vinorelbine (oral) | 02 | N | 280030196 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009176 | 280006416 | 1.76 | 66.9 | Palliative (P) | 2016-12-09 | 2016-12-30 | Dacarbazine | N | N | 280030201 | GEDDIS TRIAL |
| 280009177 | 280006417 | 1.62 | 51.3 | Palliative (P) | 2017-06-07 | 2017-06-07 | Erlotinib | 2 | N | 280030208 | IVADO |
| 280009178 | 280006418 | 1.74 | 48.5 | Curative (C) | 2015-12-03 | 2015-12-18 | VIDE | Y | N | 280030209 | FLUOROURACIL + MITOMYCIN |
| 280009179 | 280006419 | 1.85 | 68.4 | Palliative (P) | 2013-08-12 | 2013-08-13 | Ipilimumab | 2 | N | 280030215 | VIDE |
| 280009180 | 280006427 | 1.72 | 63.7 | Palliative (P) | 2017-05-05 | 2017-05-25 | ECX | N | N | 280030221 | CISPLATIN + FLUOROURACIL + RT |
| 280009181 | 280006428 | 1.63 | 51 | Palliative (P) | 2016-04-07 | 2016-04-09 | INTERFERON | 02 | N | 280030223 | GEMCARBO |
| 280009182 | 280006429 | 1.81 | 89.8 | Palliative (P) | 2014-12-07 | 2014-12-08 | TEMOZOLOMIDE | Y | Y | 280030225 | CYCLOPHOSPHAMIDE + VINORELBINE |
| 280009183 | 280006432 | 1.65 | null | null | 2014-10-17 | 2014-11-13 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 280030225 | DACTINOMYCIN + VINCRISTINE |
| 280009184 | 280009359 | 1.72 | 91.6 | Palliative (P) | 2016-06-14 | 2016-06-28 | NIVOLUMAB | 02 | N | 280030237 | CISPLATIN + FLUOROURACIL + RT |
| 280009185 | 280009359 | 1.77 | 94 | Palliative (P) | 2015-05-08 | 2015-05-14 | Cisplatin + Fluorouracil + RT 5day | N | N | 280030237 | CISPLATIN + FLUOROURACIL + RT |
| 280009186 | 280011449 | 1.5 | 52 | Neo-adjuvant (N) | 2013-03-27 | 2013-03-27 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | Y | N | 280030243 | BENDAMUSTINE + RITUXIMAB |
| 280009187 | 280011449 | 1.74 | 84.5 | Palliative (P) | 2017-07-17 | 2017-07-25 | CAPECITABINE + OXALIPLATIN | N | N | 280030243 | CARBOPLATIN + CETUXIMAB + FU |
| 280009188 | 280006435 | null | 95.6 | Palliative (P) | 2018-02-06 | 2018-03-04 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 280030257 | DOCETAXEL |
| 280009189 | 280009360 | null | null | Palliative (P) | 2013-05-13 | 2013-09-15 | Panitumumab | null | null | 280030257 | LIPOSOMAL DOXORUBICIN |
| 280009190 | 280006439 | 1.77 | null | Neo-adjuvant (N) | 2016-09-09 | 2016-09-29 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE | 02 | N | 280030262 | LIPOSOMAL DOXORUBICIN |
| 280009191 | 280006439 | 1.72 | 80 | Palliative (P) | 2016-12-14 | 2016-12-14 | Vinorelbine (oral) | null | N | 280030262 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + VINCRISTINE |
| 280009192 | 280010764 | 1.66 | 89.8 | Palliative (P) | 2014-08-23 | 2014-08-23 | Cyclophosphamide + Vincristine | 02 | N | 280030265 | DOCETAXEL |
| 280009193 | 280010764 | 1.6 | 68.9 | Curative (C) | 2016-05-27 | 2016-10-25 | CAPECITABINE + LOMUSTINE | N | N | 280030265 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 280009194 | 280006445 | 1.68 | 6 | Disease modification (D) | 2018-02-05 | 2018-02-13 | IVADo | N | N | 280030274 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE |
| 280009195 | 280006447 | 1.69 | 18.18 | Curative (C) | 2014-11-22 | 2014-11-29 | Cyclophosphamide + Topotecan | N | N | 280030275 | CARBO + FLUOROURACIL |
| 280009196 | 280006448 | 1.62 | 66 | Palliative (P) | null | 2018-02-07 | Doxorubicin + Gemcitabine | null | null | 280030275 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280009197 | 280010766 | null | null | Curative (C) | 2016-12-24 | 2017-04-01 | STS Rhabdo rel BERNIE Vinor Cyclo | null | null | 280030279 | BCG |
| 280009198 | 280006449 | 1.58 | 85.8 | Adjuvant (A) | 2013-11-25 | 2013-11-25 | VIDE | N | N | 280030280 | DOCETAXEL |
| 280009199 | 280009364 | 0 | null | Palliative (P) | 2012-01-26 | 2013-11-06 | Capecitabine | N | null | 280030281 | DOCETAXEL |
| 280009200 | 280006451 | 1.99 | 62.2 | Palliative (P) | 2017-06-02 | 2017-06-03 | Cyclophosphamide + Topotecan | 2 | N | 280030282 | CISPLATIN + ETOPOSIDE |
| 280009202 | 280010768 | 1.72 | null | Palliative (P) | 2014-07-29 | 2014-08-01 | IPILIMUMAB + NIVOLUMAB | 02 | N | 280030284 | VIDE |
| 280009203 | 280006454 | null | 19.1 | Palliative (P) | 2013-08-27 | 2015-01-24 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 280030287 | VIDE |
| 280009204 | 280006456 | 1.6 | 79.7 | Palliative (P) | 2017-05-25 | 2017-06-09 | Capecitabine | 02 | N | 280030291 | VIDE |
| 280009205 | 280006457 | null | 91.7 | Palliative (P) | 2016-02-17 | 2016-03-28 | VINCRISTINE | N | N | 280030292 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009206 | 280006458 | 1.73 | null | Palliative (P) | 2017-04-09 | 2017-04-09 | PEMBROLIZUMAB | 02 | N | 280030300 | ETOPOSIDE |
| 280009207 | 280006460 | 1.69 | 92.7 | Palliative (P) | 2018-02-13 | 2018-02-13 | Rituximab (Maintenance) | 02 | N | 280030304 | PACLITAXEL + TRASTUZUMAB |
| 280009208 | 280006461 | 1.72 | 104 | Neo-adjuvant (N) | 2017-05-05 | 2017-05-09 | Carbo F | 02 | N | 280030304 | BCG |
| 280009209 | 280006463 | 1.69 | 80.95 | Palliative (P) | 2013-03-19 | 2013-03-31 | Cisplatin + Fluorouracil + RT 5day | 02 | N | 280030312 | CARBO + FLUOROURACIL |
| 280009210 | 280006464 | 1.77 | 63 | null | 2013-05-31 | 2013-08-24 | IVADo | N | N | 280030323 | VINCRISTINE |
| 280009211 | 280006465 | 1.65 | null | null | 2017-11-01 | 2017-11-01 | VIDE | N | N | 280030329 | ETOPOSIDE |